Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

Stopping Cancer at Its Source: How the LEM-06 Discovery Is Pioneering Epigenetic Therapy

Discover how LEM-06, the first NSD2 inhibitor, is revolutionizing epigenetic cancer therapy and offering new hope for multiple myeloma patients.

Sofia Henderson
Oct 01, 2025

Popular Articles